سيفوفيسين

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only.

Convenia®

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

Convenia®

Dogs Solovecin is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G). Cats Solovecin is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Solovecin™(cefovecin sodium)

CONTRAINDICATIONS: Solovecin is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. Anaphylaxis has been reported with the use of this product in foreign market experience. If an allergic reaction or anaphylaxis occurs, Solovecin should not be administered again and appropriate therapy should be instituted. Anaphylaxis may require treatment with epinephrine and other emergency measures, including oxygen, intravenous fluids, intravenous antihistamine, corticosteroids, and airway management, as clinically indicated. Adverse reactions may require prolonged treatment due to the prolonged systemic drug clearance (65 days).

Solovecin™(cefovecin sodium)

WARNINGS: Not for use in humans. Keep this and all drugs out of reach of children. Consult a physician in case of accidental human exposure. For subcutaneous use in dogs and cats only. Antimicrobial drugs, including penicillins and cephalosporins, can cause allergic reactions in sensitized individuals. To minimize the possibility of allergic reactions, those handling such antimicrobials, including cefovecin, are advised to avoid direct contact of the product with the skin and mucous membranes.

Solovecin™(cefovecin sodium)

Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.

Subcutaneous

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only.

Convenia®

Administer 3.6 mg/pound (lb) (8 mg/kilograms (kg)) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.

Subcutaneous

Cefovecin Sodium for Injection

Dogs Solovecin should be administered as a single subcutaneous injection of 3.6 mg/lb (8 mg/kg) body weight. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete. The decision for a second injection for any individual dog should take into consideration such factors as progress toward clinical resolution, the susceptibility of the causative organisms, and the integrity of the dog's host-defense mechanisms. Therapeutic drug concentrations after the first injection are maintained for 7 days for S. intermedius infections and for 14 days for S. canis (Group G) infections. Maximum treatment should not exceed 2 injections. Cats Solovecin should be administered as a single, one-time subcutaneous injection at a dose of 3.6 mg/lb (8 mg/kg) body weight. After an injection of Solovecin, therapeutic concentrations are maintained for approximately 7 days for Pasteurella multocida infections.

SUBCUTANEOUS

Solovecin™(cefovecin sodium)